Table VI.

Survival analysis of patients in the low, medium and high-risk groups within the experimental group.

	No. of	DFS rate (%)				OS rate (%)
Groups	patients	1-year	3-years	5-years	P-value	1-year	3-years	5-years	P-value
1	52	61.5	44.2	34.6	﹤0.001	86.5	57.7	50.0	﹤0.001
2	58	34.5	20.7	17.2		55.2	31.0	22.4
3	47	14.9	6.4	6.4		40.4	17.0	12.8

DFS, disease-free survival; OS, overall survival.